1.67
18.44%
0.26
Tenaya Therapeutics Inc Stock (TNYA) Forecast
The Tenaya Therapeutics Inc (TNYA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.0683, representing a +23.85% increase from the current price of $1.67. The highest analyst price target is $3.5732, and the lowest is $0.5634.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TNYA Price Target
Average 3.7764
(+126.13% Upside)
Is Tenaya Therapeutics Inc (TNYA) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 37.58 | Neutral |
STOCH(9,6) | 15.64 | Buy |
STOCHRSI(14) | 18.62 | Buy |
MACD(12,26) | -0.2186 | Sell |
ADX(14) | 36.46 | Sell |
William %R | -77.40 | Neutral |
CCI(14) | -95.90 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
2.512
Sell
|
2.2131
Sell
|
MA20 |
2.8985
Sell
|
2.5036
Sell
|
MA50 |
2.401
Sell
|
2.511
Sell
|
MA100 |
2.3882
Sell
|
2.6165
Sell
|
MA200 |
3.2576
Sell
|
2.8408
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TNYA could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on TNYA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.58 indicates that TNYA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 15.64 indicates that TNYA is oversold. This indicates that TNYA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 18.62 indicates that TNYA is oversold. This suggests that TNYA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 36.46 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -95.9 indicates that TNYA is still oversold but not to an extreme extent.
Long-term TNYA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tenaya Therapeutics Inc financial reports and earnings history, Tenaya Therapeutics Inc (TNYA) stock could reach $5.7368 by 2030, $59.16 by 2040 and $73.55 by 2050. See the projected annual prices until 2050 of the Tenaya Therapeutics Inc stock below:
- Tenaya Therapeutics Inc (TNYA) is expected to reach an average price of $29.93 in 2035, with a high prediction of $30.14 and a low estimate of $29.91. This indicates an $1,692% rise from the last recorded price of $1.67.
- Tenaya Therapeutics Inc (TNYA) stock is projected to chart a bullish course in 2040, with an average price target of $60.30, representing an $3,511% surge from its current level. The forecast ranges from a conservative $58.83 to a sky-high $59.16.
- Our analysts predict Tenaya Therapeutics Inc (TNYA) to jump 1,632% by 2045, soaring from $29.17 to an average price of $28.93, potentially reaching $31.19. While $29.17 is the low estimate, the potential upside is significant.
- Tenaya Therapeutics Inc (TNYA) stock is expected to climb by 2050, reaching an average of $71.73, a $4,195% jump from its current level. However, a wide range of estimates exists, with high and low targets of $73.55 and $72.04, respectively, highlighting the market's uncertainty.
Tenaya Therapeutics Inc Stock (TNYA) Year by Year Forecast
Tenaya Therapeutics Inc Stock (TNYA) Price Forecast for 2025
Tenaya Therapeutics Inc Stock (TNYA) is expected to reach an average price of $3.7764 in 2025, with a high prediction of $6.9895 and a low estimate of $0.5634. This indicates an +126.13% rise from the last recorded price of $1.67.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $4.4532 | $0.5634 | $3.5732 | +166.66% |
February, 2025 | $4.643 | $5.0005 | $4.4305 | +178.02% |
March, 2025 | $5.3828 | $5.4603 | $4.8779 | +222.32% |
April, 2025 | $5.9051 | $5.5777 | $5.6251 | +253.60% |
May, 2025 | $5.9949 | $5.46 | $5.5249 | +258.97% |
June, 2025 | $6.5047 | $5.9922 | $5.6073 | +289.50% |
July, 2025 | $7.2669 | $7.0071 | $6.9895 | +335.15% |
August, 2025 | $6.8567 | $7.0018 | $6.8394 | +310.58% |
September, 2025 | $6.7766 | $6.8633 | $6.7116 | +305.78% |
October, 2025 | $6.9588 | $7.0415 | $6.9464 | +316.70% |
November, 2025 | $5.2286 | $5.3486 | $6.3913 | +213.09% |
December, 2025 | $5.2409 | $5.5509 | $5.4435 | +213.83% |
Tenaya Therapeutics Inc Stock (TNYA) Price Forecast for 2026
The predicted value for Tenaya Therapeutics Inc (TNYA) in 2026 is set at an average of $2.6654. Estimates vary from a peak of $5.2107 to a trough of $0.1201, indicating an +59.60% surge from the present price of $1.67.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $5.5107 | $5.1783 | $5.2107 | +229.98% |
February, 2026 | $2.2205 | $4.9897 | $5.0831 | +32.96% |
March, 2026 | $0.1403 | $1.1703 | $1.453 | -91.60% |
April, 2026 | $0.4526 | $0.1201 | $0.8613 | -72.90% |
May, 2026 | $1.4024 | $1.5675 | $1.1224 | -16.03% |
June, 2026 | $2.0122 | $1.7648 | $1.8422 | +20.49% |
July, 2026 | $2.5244 | $2.482 | $2.2944 | +51.16% |
August, 2026 | $3.4643 | $3.0493 | $3.0093 | +107.44% |
September, 2026 | $3.8565 | $3.6792 | $3.7965 | +130.93% |
October, 2026 | $3.5663 | $3.6563 | $3.4163 | +113.55% |
November, 2026 | $3.0561 | $3.1961 | $3.2912 | +83.00% |
December, 2026 | $0.9684 | $1.9991 | $2.0036 | -42.01% |
Tenaya Therapeutics Inc Stock (TNYA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tenaya Therapeutics Inc (TNYA) is $7.728, with a high forecast of $15.44 and a low forecast of $0.0129. This indicates an +362.76% increase from the last price of $1.67.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $1.1518 | $0.3857 | $1.2307 | -31.03% |
February, 2027 | $2.412 | $0.6694 | $2.452 | +44.43% |
March, 2027 | $0.7697 | $0.0129 | $2.8195 | -53.91% |
April, 2027 | $0.8899 | $0.2524 | $0.9899 | -46.71% |
May, 2027 | $5.8598 | $0.8875 | $7.582 | +250.89% |
June, 2027 | $0.1443 | $3.1593 | $5.6245 | -91.36% |
July, 2027 | $7.1039 | $0.6292 | $6.4339 | +325.39% |
August, 2027 | $4.8536 | $8.0236 | $4.8089 | +190.63% |
September, 2027 | $15.12 | $7.5985 | $15.44 | +805.27% |
October, 2027 | $12.06 | $12.36 | $13.11 | +622.02% |
November, 2027 | $12.83 | $13.14 | $12.57 | +668.10% |
December, 2027 | $9.8618 | $11.26 | $12.19 | +490.53% |
Tenaya Therapeutics Inc Stock (TNYA) Price Forecast for 2028
In 2028, Tenaya Therapeutics Inc (TNYA) is projected to reach an average price of $14.62, with a high projection of $16.85 and a low estimate of $12.39. This indicates an +775.47% rise from the last price of $1.67.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $15.97 | $12.39 | $13.54 | +856.37% |
February, 2028 | $16.00 | $16.35 | $15.78 | +858.15% |
March, 2028 | $16.40 | $16.32 | $16.03 | +881.77% |
April, 2028 | $16.60 | $16.46 | $16.08 | +893.73% |
May, 2028 | $16.40 | $16.00 | $16.30 | +882.02% |
June, 2028 | $16.64 | $16.19 | $15.94 | +896.37% |
July, 2028 | $17.27 | $17.07 | $16.85 | +934.07% |
August, 2028 | $16.38 | $16.66 | $16.71 | +881.05% |
September, 2028 | $16.03 | $16.12 | $16.10 | +860.07% |
October, 2028 | $15.96 | $16.16 | $15.93 | +855.85% |
November, 2028 | $13.88 | $14.00 | $15.68 | +730.97% |
December, 2028 | $13.96 | $14.00 | $13.96 | +735.74% |
Tenaya Therapeutics Inc Stock (TNYA) Price Forecast for 2029
The 2029 price forecast for Tenaya Therapeutics Inc Stock (TNYA) is $10.21 on average, with a high prediction of $13.52 and a low estimate of $6.9019. This represents an +511.49% increase from the previous price of $1.67.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $13.55 | $13.42 | $13.52 | +711.46% |
February, 2029 | $9.991 | $12.76 | $13.06 | +498.26% |
March, 2029 | $7.6406 | $8.6706 | $9.156 | +357.52% |
April, 2029 | $7.3502 | $7.3502 | $7.3654 | +340.13% |
May, 2029 | $8.2947 | $7.8451 | $8.0698 | +396.69% |
June, 2029 | $8.6344 | $8.5844 | $8.4644 | +417.03% |
July, 2029 | $8.834 | $8.834 | $8.4943 | +428.98% |
August, 2029 | $9.4785 | $8.8489 | $9.0235 | +467.58% |
September, 2029 | $9.7281 | $9.5583 | $9.4281 | +482.52% |
October, 2029 | $8.9726 | $9.0626 | $9.473 | +437.28% |
November, 2029 | $8.1923 | $8.3323 | $8.6075 | +390.55% |
December, 2029 | $6.6719 | $6.9019 | $7.0722 | +299.51% |
Tenaya Therapeutics Inc Stock (TNYA) Price Forecast for 2030
Tenaya Therapeutics Inc Stock (TNYA) is expected to reach an average price of $15.22 in 2030, with a high forecast of $28.28 and a low forecast of $2.1609. This signifies an +811.40% surge from the last price of $1.67.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $3.3764 | $4.9464 | $5.7368 | +102.18% |
February, 2030 | $1.846 | $2.558 | $2.5713 | +10.54% |
March, 2030 | $2.7456 | $2.1609 | $2.7207 | +64.41% |
April, 2030 | $3.1252 | $3.3854 | $2.9103 | +87.14% |
May, 2030 | $19.84 | $2.6951 | $21.70 | +1,088% |
June, 2030 | $15.55 | $19.54 | $19.41 | +831.39% |
July, 2030 | $20.48 | $14.21 | $19.81 | +1,126% |
August, 2030 | $17.96 | $21.13 | $18.12 | +975.47% |
September, 2030 | $29.00 | $20.64 | $28.28 | +1,637% |
October, 2030 | $24.56 | $24.86 | $26.73 | +1,370% |
November, 2030 | $25.06 | $25.50 | $24.93 | +1,400% |
December, 2030 | $23.38 | $24.27 | $24.29 | +1,300% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):